A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208)

Annals of Surgery ◽

10.1097/sla.0000000000002865 ◽

2019 ◽

Vol 270 (2) ◽

pp. 230-237 ◽

Author(s):

Shogo Kobayashi ◽

Hiroaki Nagano ◽

Akira Tomokuni ◽

Kunihito Gotoh ◽

Daisuke Sakai ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Major Hepatectomy ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽

10.1016/j.esmoop.2021.100314 ◽

2022 ◽

Vol 7 (1) ◽

pp. 100314

Author(s):

M.M. Javle ◽

D.-Y. Oh ◽

M. Ikeda ◽

W.-P. Yong ◽

K. Hsu ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Second Line ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

A multi-center randomized phase II study of nivolumab in combination with gemcitabine/cisplatin or ipilimumab as first line therapy for patients with advanced unresectable biliary tract cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps4142 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS4142-TPS4142 ◽

Author(s):

Vaibhav Sahai ◽

Kent A. Griffith ◽

Muhammad Shaalan Beg ◽

Mark Zalupski

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

6596 POSTER A Randomized Phase II Study of Gemcitabine (GEM) Plus S-1 Combination Chemotherapy Versus GEM Monotherapy in Patients (pts) With Advanced Biliary Tract Cancer (BTC) – GS-COMBI Study

European Journal of Cancer ◽

10.1016/s0959-8049(11)71907-4 ◽

2011 ◽

Vol 47 ◽

pp. S470

Author(s):

T. Sasaki ◽

H. Isayama ◽

Y. Ito ◽

I. Yasuda ◽

N. Toda ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Combination Chemotherapy ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Post-hoc analyses of a subgroup of patients with advanced biliary tract cancer (BTC) who crossed over to treatment with etoposide toniribate (EDO-S7.1) in a randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.051 ◽

2019 ◽

Vol 30 ◽

pp. v278 ◽

Author(s):

U.-F. Pape ◽

S. Kasper ◽

J. Meiler ◽

M. Sinn ◽

A. Vogel ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii ◽

Download Full-text

A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2090-4 ◽

2013 ◽

Vol 71 (4) ◽

pp. 973-979 ◽

Author(s):

Takashi Sasaki ◽

Hiroyuki Isayama ◽

Yousuke Nakai ◽

Yukiko Ito ◽

Ichiro Yasuda ◽

...

Keyword(s):

Combination Therapy ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

Annals of Oncology ◽

10.1016/j.annonc.2021.08.2082 ◽

2021 ◽

Vol 32 ◽

pp. S1282

Author(s):

L. Perkhofer ◽

J.K. Striefler ◽

M. Sinn ◽

B. Opitz ◽

T.O. Goetze ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Tract Cancer ◽

Cancer Group ◽

Randomized Phase Ii

Download Full-text

Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3087 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3087-3087

Author(s):

Tetsuro Sasada ◽

Shigeru Yutani ◽

Satoko Matsueda ◽

Takashi Shirahama ◽

Akira Yamada ◽

...

Keyword(s):

Cancer Patients ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Peptide Vaccination ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)

Annals of Oncology ◽

10.1093/annonc/mdy282.145 ◽

2018 ◽

Vol 29 ◽

pp. viii260

Author(s):

H. Terajima ◽

S. Kobayashi ◽

H. Nagano ◽

A. Tomokuni ◽

K. Gotoh ◽

...

Keyword(s):

Adjuvant Chemotherapy ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Major Hepatectomy ◽

Phase Ii Trial ◽

Oncology Group ◽

Tract Cancer ◽

Randomized Phase Ii

Download Full-text

Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)

Cancer Science ◽

10.1111/cas.12218 ◽

2013 ◽

Vol 104 (9) ◽

pp. 1211-1216 ◽

Author(s):

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Atsuo Takashima ◽

Makoto Ueno ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Tract Cancer ◽

Randomized Phase Ii ◽

Download Full-text

Faculty Opinions recommendation of Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995584.793475609 ◽

2013 ◽

Author(s):

Piero Portincasa ◽

Leonilde Bonfrate

Keyword(s):

Folinic Acid ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

Download Full-text